SCHEMBL26217468

SCHEMBL26217468

CCN(CC(=O)N(C)c1ccc(OC)cc1)c1ccc(OC)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
HTT P42858 1/20 0.47
LMNA P02545 3/20 0.46
MAPT P10636 5/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MAPK1 P28482 2/20 0.46
GAA P10253 1/20 0.46
GFER P55789 1/20 0.46
NPC1 O15118 2/20 0.45
TP53 P04637 2/20 0.45
RAB9A P51151 1/20 0.45
ESR2 Q92731 1/20 0.45
NOX1 Q9Y5S8 1/20 0.45
MCHR1 Q99705 2/20 0.45
PPIB P23284 1/20 0.45
HSP90AA1 P07900 1/20 0.43
PDK1 Q15118 1/20 0.43
PDK2 Q15119 1/20 0.43
PDK3 Q15120 1/20 0.43
PDK4 Q16654 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26217384 0.94 LMNA (0.51) ALDH1A1LMNAMAPTSMN1; SMN2NPC1
SCHEMBL26217430 0.87 CETP (0.43) ALDH1A1LMNAMAPTTP53MCHR1
SCHEMBL26264796 0.85 ALDH1A1 (0.45) ALDH1A1HTTLMNAMAPTSMN1; SMN2
SCHEMBL26217594 0.85 ALDH1A1 (0.46) ALDH1A1HTTLMNAMAPTSMN1; SMN2
SCHEMBL26217412 0.85 BCL2A1 (0.47) LMNAMAPTTP53MCHR1POLB
SCHEMBL26217487 0.84 LMNA (0.45) ALDH1A1LMNAMAPTSMN1; SMN2MAPK1
SCHEMBL26217450 0.84 LMNA (0.45) ALDH1A1LMNAMAPTGAANPC1
SCHEMBL6172845 0.82 KEAP1 (0.55) ALDH1A1MAPTSMN1; SMN2MAPK1GAA
SCHEMBL26217525 0.82 HSD17B1 (0.43) ALDH1A1HTTLMNAMAPTSMN1; SMN2
SCHEMBL8280402 0.82 PPIB (0.50) ALDH1A1HTTLMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230399292-A1 ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS PTC Innovations, LLC 2023-12-14 US disclosed
US-20230399291-A1 ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS PTC INNOVATIONS LLC (US) 2023-12-14 US disclosed
US-20230399290-A1 ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS PTC INNOVATIONS LLC (US) 2023-12-14 US disclosed
US-20230373906-A1 ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS PTC INNOVATIONS LLC (US) 2023-11-23 US disclosed
US-11814335-B1 Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms PTC Innovations, LLC (US) 2023-11-14 US disclosed
US-11786493-B2 Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms PTC Innovations, LLC (US) 2023-10-17 US disclosed
WO-2023172603-A1 ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS PTC Innovations, LLC (US) 2023-09-14 WO disclosed
US-20230286905-A1 ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS PTC Innovations, LLC 2023-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230399290-A1 ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS OPRK1, ACHE, F5 ALDH1A1 840/4885HTT 4540/4885LMNA 2285/4885
US-20230399292-A1 ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS OPRM1, OPRL1, OPRK1 ALDH1A1 676/4885HTT 2158/4885LMNA 2668/4885
US-20230399291-A1 ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS CHRM2, RXFP2, OPRM1 ALDH1A1 1968/4885HTT 4744/4885LMNA 3130/4885
US-11814335-B1 Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms F8, F5, OPRM1 ALDH1A1 881/4885HTT 4331/4885LMNA 2286/4885
US-20230286905-A1 ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS OPRM1, OPRL1, OPRK1 ALDH1A1 409/4885HTT 3301/4885LMNA 3532/4885
US-20230373906-A1 ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS F5, EIF4G2, ACHE ALDH1A1 853/4885HTT 3981/4885LMNA 2318/4885
US-11786493-B2 Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms OPRM1, OPRL1, OPRK1 ALDH1A1 409/4885HTT 3301/4885LMNA 3532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.